healthcare News
Novo Nordisk Shares Under Pressure After Steep Medicare Price Cut for Ozempic
Deal secures access for its blockbuster weight-loss drugs but forces a 70% price reduction, fueling concerns over future profitability.
Lantheus Shares Climb on Favorable CMS Ultrasound Ruling
A federal decision to double payment for contrast-enhanced ultrasound scans is expected to boost adoption, benefiting the company's market-leading imaging agent.
Eli Lilly Breaches $1 Trillion Valuation on New Obesity Drug Strategy
Pharma giant partners with Ilant Health to offer its blockbuster weight-loss drugs directly to employers, bypassing traditional health insurance pathways.
ByHeart Formula Recall May Boost Rivals Abbott, Perrigo
An FDA botulism investigation into a private formula maker is sparking a potential 'flight to quality' in the highly sensitive infant nutrition market.
Obesity Drugmakers Rally on White House Medicare Deal Reports
Eli Lilly and Novo Nordisk shares climb amid expectations of a landmark agreement to expand Medicare and Medicaid access for blockbuster weight-loss drugs.
Weight-Loss Drug Stocks Tumble on Trump Pricing Pressure Report
Novo Nordisk and Eli Lilly shares fall after a report details potential negotiations to slash U.S. drug prices by nearly 90%, threatening a high-growth sector.
Eli Lilly Taps Walmart to Expand Zepbound Retail Access
The partnership leverages Walmart's vast pharmacy network for Lilly's direct-to-consumer platform, intensifying the battle for the multi-billion-dollar weight-loss drug market.
Novartis' Leqvio study shows promise in cholesterol treatment
Phase IV trial data reveals the drug helps patients achieve LDL-C goals with reduced muscle pain, bolstering its market position.